Yuanli Chemical Group Co.,Ltd.

SSE:603217.SS

17.05 (CNY) • At close May 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 544.4502.329578.057582.824549.419497.048591.737527.135563.86550.37631.411741.624759.577628.979686.887568.599458.992367.352318.464287.531248.682271.283282.473306.21307.375319.517368.387366.566312.947
Cost of Revenue 451.394409.243489.092484.221462.696417.552488.12428.405454.561434.996487.919504.077551.383479.798539.608429.824335.5298.415243.553217.836201.648219.618220.502219.151220.394220.177236.329234.962209.137
Gross Profit 93.00693.08688.96698.60386.72279.495103.61798.73109.299115.374143.492237.547208.193149.181147.278138.775123.49268.93774.91169.69547.03451.66561.97187.0686.98199.34132.058131.604103.81
Gross Profit Ratio 0.1710.1850.1540.1690.1580.160.1750.1870.1940.210.2270.320.2740.2370.2140.2440.2690.1880.2350.2420.1890.190.2190.2840.2830.3110.3580.3590.332
Reseach & Development Expenses 22.5720.98424.14330.38218.64421.8723.63622.99822.7425.19326.00931.99132.10924.03524.56320.05119.3318.13514.62312.9528.69310.7738.8269.049.91210.05611.45410.74310.743
General & Administrative Expenses 16.039-36.00643.354-6.35914.994-24.39336.091-3.1415.773-14.85638.6038.33517.575-15.07623.177-3.957.641-18.2167.284-5.0368.654-17.62111.1598.8838.044-18.4049.3828.2928.292
Selling & Marketing Expenses 4.326-3.15-22.2074.8993.0362.9373.7215.0913.8192.9793.7694.4933.9133.2583.462.7623.139-19.69512.3910.4874.77617.72711.7499.443.76113.5047.3927.0317.031
SG&A 20.365-39.15621.148-1.4620.73816.73939.8121.95219.593-11.87742.37212.82821.488-11.81826.637-1.18810.78-37.91119.6745.45113.430.10622.90817.87313.037-4.916.77415.47415.474
Other Expenses -5.7847.81800.0110.005-0.809-0.1510.007-2.65836.415-14.22418.110.537-1.6630.01712.3780-0.11-015.0610.418-1.2877.886-28.432-27.9980.099-0.8-33.985-33.22
Operating Expenses 37.15529.64637.75650.46839.38239.41747.25147.59639.67549.73154.15762.9354.13546.90939.47131.24130.5538.85332.75833.46522.54142.70234.284-28.432-27.99844.46630.884-33.985-33.22
Operating Income 55.85163.4443.67659.38847.3440.07866.47771.23475.59872.01112.202195.404159.52499.542115.872111.07496.03857.19147.3147.6833.42419.97535.83358.62858.98352.187103.70797.61970.589
Operating Income Ratio 0.1030.1260.0760.1020.0860.0810.1120.1350.1340.1310.1780.2630.210.1580.1690.1950.2090.1560.1490.1660.1340.0740.1270.1910.1920.1630.2820.2660.226
Total Other Income Expenses Net -0.548-2.39611.1540.01117.210.017-0.1510.0070.007-2.3250.0440.279-0.548-1.6630.0170.4880-0.11-0-0.0940-1.2877.886-0.053-0.0060.099-0.813.489-33.193
Income Before Tax 55.30261.04454.82959.39964.5581.16866.32771.24175.60669.685112.246195.683158.97697.878115.889111.56396.03857.08147.3147.58633.42418.68843.71958.57558.97752.286102.90697.59370.617
Income Before Tax Ratio 0.1020.1220.0950.1020.1170.1630.1120.1350.1340.1270.1780.2640.2090.1560.1690.1960.2090.1550.1490.1650.1340.0690.1550.1910.1920.1640.2790.2660.226
Income Tax Expense 8.70710.8975.1497.5929.05521.5939.238.60211.622-1.26713.69129.98824.85312.54516.79517.86514.05210.5175.5766.0925.4244.6129.45714.08315.51812.49627.03224.5917.758
Net Income 46.59550.14749.6851.80755.49565.9657.09662.63963.98370.95298.555165.695134.12485.33399.09593.69781.98646.56441.73341.4952814.07734.26244.49243.45939.7975.87573.00452.859
Net Income Ratio 0.0860.10.0860.0890.1010.1330.0960.1190.1130.1290.1560.2230.1770.1360.1440.1650.1790.1270.1310.1440.1130.0520.1210.1450.1410.1250.2060.1990.169
EPS 0.220.2410.240.250.270.330.270.30.310.380.470.80.640.450.460.470.40.230.210.20.140.0690.20.290.280.260.60.410.41
EPS Diluted 0.220.2410.240.250.270.330.270.30.310.380.470.80.640.450.460.470.390.230.210.20.140.0690.20.290.280.260.60.410.41
EBITDA 57.3363.12154.84159.40488.098105.37590.55395.08699.4691.286133.844215.203178.499120.898138.684132.95117.42682.52467.4356.51753.6537.42562.20173.15886.98154.308105.06168.227103.81
EBITDA Ratio 0.1050.1260.0950.1020.160.2120.1530.180.1760.1660.2120.290.2350.1920.2020.2340.2560.2250.2120.1970.2160.1380.220.2390.2830.170.2850.1860.332